Marketresearchnews

Thursday, 27 August 2020

Asthma Device Market Value Share, Supply Demand, Share And Value Chain analysis 2019

Market Synopsis of Global Asthma Devices Market

Asthma is a chronic inflammatory lung disease that narrows the airways. Asthma causes recurring periods of wheezing, chest tightness, shortness of breath, and coughing. Mostly, the symptoms associated with asthma are short-lived and can be easily treated. Asthma inhalers are medical devices which deliver medication into the body via the lungs, thereby, treating asthma and chronic obstructive pulmonary disease. Increasing prevalence of asthma is one of the major drivers for the market growth. According to the World Health Organization in 2017, approximately 235 million people suffered from asthma. Moreover, it was estimated that in 2015, the disease killed approximately 383 million patients around the globe. Additionally, rising healthcare expenditures and increasing awareness fuel the market growth. However, long treatment procedures and low per capita income followed by lack of favorable reimbursement policies in the developing countries will restrain the market growth during the forecast period.

The global asthma devices market size is expected to grow at an approximate CAGR of 4.3% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1624

Segmentation

The global copd and asthma devices market is segmented on the basis of type, technology, and end users.

On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.

On the basis of technology, the market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.

On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.

Regional Analysis

The Americas dominate the global asthma devices market owing to a well-developed healthcare sector and huge patient population for asthma diseases. According to the Centres for Disease Control and Prevention, in 2015, approximately, 7.8% of the total population in the U.S. was identified for the presence of asthma. Moreover, changing lifestyle and increasing healthcare expenditure fuels the market growth. Additionally, the presence of global players like Merck & Co., Inc. and Baxter, and others boost market growth during the forecast period.

Europe is the second largest asthma devices market owing to a well-developed healthcare infrastructure and huge patient population. Moreover, government support for research & development and rising healthcare expenditures fuel the market growth. According to a study published in the Asthma Research and Practice journal in 2017, the yearly estimated cost for all the asthmatics per patient is about USD 1,900. Additionally, the presence of the developed economies like the U.K, Germany, and France within the region boosts the market growth.

Asia Pacific is the fastest growing region in the global market due to the presence of a huge patient population and continuously developing economies like India and China. According to a study of the Indian Chest Society in 2015, 300 million people suffered from asthma worldwide and about a tenth of its share is in India. Moreover, as per the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax along boosts the market growth.

On the other hand, the Middle East & Africa holds the least share of the global asthma devices market due to the presence of poor economy, especially within the African region. The absence of the developed healthcare sector and stringent government policies restrain the market growth within the African region. Majority of the market within the region is held by the Middle East due to huge healthcare expenditures.

Key players for global asthma devices market

GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.Top of Form

Browse More Details of the Report @Bottom of Form https://www.marketresearchfuture.com/reports/asthma-devices-market-1624

Bone Biopsy Bone Biopsy Market, Segments, Growth And Value Chain Analysis 2019

Market Scenario

Bone Biopsy market growth is driven by increasing prevalence of chronic diseases such as Chronic Kidney Disease (CKD) and demand new diagnostic services. Additionally, increasing research and development activities, technological advancements to identify the causes and risk factors associated with osteopenia and osteoporosis also fuel the market growth of global market.

The Global Bone Biopsy System Market Size is expected to grow at a CAGR of 5.7% during the forecast period.

According to the World Health Organisation (WHO), cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to the Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5341

Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from last few years.

Key Players in the Global Bone Biopsy Market

C R Bard (U.S.),
Becton,
Dickinson and Company (U.S.),
Braun Melsungen AG,
Hologic, Inc. (U.S.),
Cook Medical (U.S.),
Devicor Medical Products Inc. (U.S.),
Argon Medical Inc. (U.S.)

Segmentation

The global bone biopsy market is segmented on the basis of type, indication and end user.

On the basis of the component, market is segmented into needle biopsy and open biopsy.

On the basis of the application, the market is segmented into bone cancer, bone infection, chronic kidney disease, osteoporosis, and others

On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, diagnostic centers, and others.

Regional Analysis

America holds the first position in the bone biopsy market owing to the rising prevalence of cancer in the U.S. and increasing demand for new cancer diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare diagnostic industry. The prevalence of osteoporosis is found to be higher in the population over 35 years for age. Changing lifestyle, emphasis on fitness and exercise, and overall development of medical device industry also accelerate the growth of the market.

Europe is the second largest market for bone biopsy. In Europe, there is an increasing demand for advanced bone biopsy devices, and extensive research and development activities by clinical research and academic institutes for cancer diagnosis and treatment. Germany is the largest market followed by France. The market in Germany is driven by increasing demand for specialty care services.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as kidney disease, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand of technologically advanced medical devices in diagnostic centers and availability of highly qualified medical professional dedicated to research in oncology. Additionally, rising healthcare expenditure and extensive growth of medical device industry also influence the use of medical devices for diagnosis of various diseases such as osteoporosis, diabetes, cancer, and others.

The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about cancer treatment. In the Middle East & Africa, United Arab Emirates captures the largest market share for bone biopsy owing to the availability of better healthcare infrastructure and a wide scope for research. In Africa, the market also shows a positive growth owing to development of healthcare system in African countries, and increasing demand for primary care services.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bone-biopsy-market-5341

Americas Blood Glucose Test Strip Packaging Market 2019 Analysis, Opportunities And Forecast To 2021

Americas Blood Glucose Test Strip Packaging Market Information, by product (diagnostic, therapeutics, medical care and nutrition and wellness) by application (diagnosis and intervention, drug development and usage, cancer genomics and others), by End users (hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others)- Forecast to 2023

Market Synopsis of Americas Blood Glucose Test Strip Packaging Market:

An expert on premium research reports, Market Research Future has added a report titled "Americas Blood Glucose Test Strip Packaging Market Research Report – Forecast to 2021" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Americas Blood Glucose Test Strip Packaging Market– Forecast to 2021 The report firstly introduced Americas Blood Glucose Test Strip Packaging Market including classification, application and industry chain overview; Then we deeply analyzed Americas growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Americas Blood Glucose Test Strip Packaging Market trends. We are thankful for the support and assistance from Americas Blood Glucose Test Strip Packaging Market chain related technical experts and marketing experts during Research Team survey and interviews.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/americas-blood-glucose-test-strip-packaging-industry-576

Detailed Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of The Study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.3 Growth Barriers

4.4 Growth Opportunities

4.5 Macroecnomical Indicators

5 Market Analysis

6 Americas Blood Glucose Test Strip Market

6.1 Introduction

6.2 By Volume

6.3 By Value

7 Americas Blood Glucose Test Strip Packaging Market, By Product Type

7.1 Introduction

7.2 Plastic Vials

7.2.1 Plastic Vials With Loose Desiccant

7.2.2 Plastic Vials With Injected Desiccant

7.3 7.2.3 Plastic Vials With Other Desiccant

7.2.4 Plastic Vials Without Desiccant

7.3 Aluminium Foils By Value

7.4 Others

…TOC Continued!

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/576

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Latest Study Offers Detailed Insights On Enema Based Products Market 2019

Market Synopsis of the Global Enema Based Products Market

The global enema based products market is expected to show sharp growth over the forecast period. Rising Enema Based Products Market demand and prevalence of gastrointestinal disorders such as constipation across the globe, availability of various types of enema administration kits such as cleansing and carminative enema and overall demand for enema administration products drivers the market growth.

Enema based products are used to remove waste for the rectum and can be used at home as a remedial measure for constipation and other gastrointestinal disorders. Constipation is a major gastrointestinal condition, found to be prevalent across the globe. Other condition that may require enema administration are obesity, diabetes, and cancer.

Risk involved in the use of enema based product is irritation in the rectum and embolism, in case of incorrect use of enema administration

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4370

According to the latest 2016 data from the World Health Organization, an estimated 422 million adults were living with diabetes mellitus across the globe.

The global enema based products market is expected to grow at a CAGR of 10.2% during the forecast period.

Key Players

Some of the key players in this market are Baxter International, Inc. (U.S), MacoPharma (U.K), Hollister Incorporated (U.S), Coloplast Group (Germany), Medline Industries, Inc. (U.S), and B Braun Melsungen AG (Germany).

Segments
The global enema based products market is segmented on the basis of administration type, indication, preparation, and end users.

On the basis of administration type, market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.

On the basis of indication, the market is market is segmented into constipation, diarrhea, obesity, cancer and others.

On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas and others. Barium enemas is further segmented into single-column barium enema and double-contrast barium enema.

On the basis of end user, the market is divided into hospitals or clinics, home, and others.

Regional Analysis

The global enema based products market size by regional basis is segmented into regions namely Americas, Europe, Asia Pacific and the Middle East & Africa. America is the largest market for enema based products owing to increasing use of enema based products at home, and rising demand for enema kits by healthcare providers. According to the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. One of the study stated that the 20% of the North American population suffer from constipation.

Europe is the second largest market owing rise in the number of enema administration procedures in the hospitals. Rising prevalence of constipation, diarrhea, and obesity also contributes to the progress of the market. Prevalence of diabetes is also found to be increasing in the Europe. According to the World Health Organization, nearly 60 million people with diabetes in the European Region and the prevalence is higher among people aging 25 years and above.

In Asia Pacific, the prevalence of chronic diseases such as diabetes and obesity is found to be increasing. Diabetes is one of the major problem in China and India. India has world’s second largest population of diabetic patients, around 69.2 million in 2015 and that are expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.

The Middle East & Africa also shows a steady rise in the market owing to lack of physical exercise, increasing problem of constipation and availability of enema based products in the market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/enema-based-products-market-4370

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Tendinitis treatment Market Trends, Size And Growth Analysis 2019 To 2023

Market Scenario:

An expert on premium research reports, Market Research Future predicts that Global tendinitis treatment market is expected to grow at the CAGR of ~3.8% during the forecast period and is estimated to reach USD 426.4 million by 2023. According to a recent study report published by the Market Research Future, the global tendinitis treatment market growth is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing USD 426.4 million with a constant CAGR during the anticipated period (2017 – 2023).

Tendinitis is the inflammation of the tendon, thick cords that attach the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus. In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction. Tendinitis is found to be prevalent among athletes and is one of the common sport injuries in sport players, especially tennis, golf and others. Various pharmacological and non-pharmacological treatments are available for the treatment of tendinitis. Non-steroidal anti-inflammatory drugs (NSAIDs) constitute the preliminary treatment options. Other treatments including physical therapy, rest, and occupational therapy. Surgery is the last resort for tendinitis, and is only recommended in case of severe damage to the tendon that cannot be treated using pharmacological treatment options.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3876

Key players for Global Tendinitis Treatment Market:

Almatica Pharma, Inc. (US),
AstraZeneca (US),
Bayer (Germany),
Boehringer Ingelheim Pharmaceuticals, Inc. (US),
Merck & Co., Inc (US),
Pfizer (US).

Intended Audience:

Tendinitis medicines manufacturers
Tendinitis medicines and treatment providers
Medical Research laboratories
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors

Segments:

Global tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's knee, and others.

On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.

On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional analysis

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly includes North America and South America. Due to developed healthcare infrastructure and increasing R&D funding, US is dominating country in this region. Europe is second largest market for tendinitis treatment. Due to innovative product development and rapid adoption of new treatments, Germany is dominating this market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and Africa is expected to have limited growth while Middle Eastern countries are expected to dominate this market during the forecast period.

Competitive Analysis

The market for tendinitis treatment is characterised by the presence of several well-established and small players, the global market of tendinitis treatment appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The tendinitis treatment market appears to be highly competitive owing to the presence of several large and small key players accounting for a substantial market share. Many leading players are concentrated in the Americas owing to well-established market and high healthcare expenditures; these players have expanded their market in other region as well. Furthermore, the companies such as Abbott, AstraZeneca, Teva, and Pfizer are well-established in European market. The major four players namely Abbott, AstraZeneca, Teva, and Pfizer accounted for more than 17% share of the Americas and Europe tendinitis market.

In April 2017, Pfizer entered into a merger with Allergan to gain access for Allergan's portfolio including Botox, Viagra, the Prevnar pneumonia vaccine, and treatments for ailments including Alzheimer’s and rheumatoid arthritis.

Furthermore, in July 2017, Merck & Co.Inc & AstraZeneca entered into strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s LYNPARZA (olaparib) for multiple cancer types.

Furthermore, in November 2016, AstraZeneca announced a licensing agreement between MedImmune, its global biologics research and development arm, and Allergan plc., for the global rights to MEDI2070.

Moreover, May 2014, the company acquired Merck & Co., Inc.’s non-prescription business to become the OTC leader in North America and Latin America & achieve top global positions in key OTC product categories.

Therefore, the growing key business strategies will help the key competitors to expand their presence in various parts of the globe for their competitive products and will has spurred the growth of the market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/tendinitis-treatment-market-3876

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Keratoconus treatment Market Dynamics, Forecast, Analysis And Supply Demand 2019

Market Scenario:

The Global Keratoconus Treatment Market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future.

Approximately 3 million people are affected by this disease across the globe. Advanced diagnostic and treatment options are key drivers for this market. Increasing awareness of the disease, increasing funding for R&D and growing demand from emerging regions such as Asia are major driving forces of the market. Major players of this market are investing in R&D to develop effective solution for keratoconus. Introduction of wide range of lenses is important factor for market growth.

The market for keratoconus treatment was around USD 322.7 million in 2016 and is expected to reach USD 427.5 million by 2023 which is a projected CAGR of 4.1%.

Keratoconus KC is a condition of the eye which results in liberal thinning of the cornea. This may result in blurry vision, double vision, near sightedness, astigmatism, and light sensitivity. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea. While the cause is unknown, it is thought to occur due to a combination of genetic, environmental, and hormonal factors.

Further about seven percent of those affected have a family history of the condition, proposed environmental factors comprise of rubbing eyes and allergies. The fundamental mechanism involves changes of the cornea to a cone shape. Diagnosis is by examination with a slit lamp.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3861

Moreover initially the condition can typically be corrected with glasses or soft contact lenses. As the disease worsens special contact lenses may be required. In most people the disease stabilizes after a few years without severe vision problems. In a small number of Keratoconus KC is a condition of the eye which results in liberal thinning of the cornea. This may result in blurry vision, double vision, near sightedness, astigmatism, and light sensitivity. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea. While the cause is unknown, it is thought to occur due to a combination of genetic, environmental, and hormonal factors.

Key Players for Global Keratoconus Treatment Market:

Some of the key players in this market are: Bausch & Lomb Incorporated (US), CIBA VISION (US), CooperVision (US), HOYA Vision Care (Singapore), Johnson & Johnson Vision Care, Inc. (US), Menicon Co., Ltd. (Japan), Novartis AG (Switzerland), Optik Seis (Indonesia), and SAFILENS S.R.L. (Italy), and others.

Segmentations:

Global keratoconus treatment market has been segmented on the basis of type which comprises of forme fruste keratoconus, corneal hydrops, keratoglobus, pellucid marginal degeneration, posterior keratoconus, and others.

On the basis of end user, it is segmented into eye hospitals & clinics, medical research centers, academic institutes, and others.

On the basis of diagnosis, the market is segmented into computerized corneal mapping, keratometry, slit-lamp examination, refraction test, and others. Slit-lamp examination includes tonometry, vision testing, and others.

On the basis of treatments, the market has been segmented into lenses, surgery, collagen cross-linking, and others. Lenses is sub-segmented into eyeglasses or soft contact lenses, hard contact lenses, piggyback lenses, hybrid lenses, scleral lenses, and others. Surgery is sub-segmented into corneal inserts, cornea transplant, and others. Collagen cross-linking is still in research process and more study is required to implement this treatment option.

Regional Analysis

Considering the global scenario of the market, America is the highest revenue generator with North American region contributing the most. North America mainly includes US and Canada. US is one of the dominant markets not only in America but also in the global market. European market is the second largest and UK is believed to be the fastest growing market for keratoconus treatment in this region. Increasing awareness, growing purchasing power, and rapidly improving healthcare sector are driving the growth for Asia Pacific keratoconus market. Asia Pacific is one of the high potential market for keratoconus treatment. Due to slow adoption of new treatments and prosucts, Middle East and Africa is expected to grow at steady pace.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/keratoconus-treatment-market-3861

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Market Therapeutics In Global Markets To 2023 - Growth Driven By Increasing Uptake Of Targeted Therapies And Rising Prevalence

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Fertility Services Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Fertility Services Market Detail Overview:

The Global Fertility Services Market is projected to experience growth at a CAGR close to 8.50% and reach a significant valuation over the forecast period of 2018-2023, reveals Market Research Future (MRFR) in a minutely analyzed report. Growing urbanization, and changing, unhealthy lifestyles have affected the fertility rate consequently which intensifies the need for adopting fertility services. With the rise in female literacy rate, women are increasingly joining the workforce which results in delayed marriages and late conception.

Also Read : https://www.globenewswire.com/news-release/2018/08/09/1549518/0/en/Fertility-Services-Market-Size-at-8-50-CAGR-with-Recent-Technologies-and-Global-Industry-Trends-by-2023-MRFR.html

Moreover, factors such as the prevalence of ovulatory disorders, and excessive smoking and alcohol intake among women are also significant causes for infertility among women which has escalated in the fast few years and driven the fertility services market. Fertility services are comparatively less expensive in emerging markets such as Asia Pacific and MEA. It encourages medical tourism and boosts the market growth.

There has been a significant rise in the numbers of male fertility rates caused by an unhealthy lifestyle and smoking and drinking habits. Advancements in fertility treatments have also boosted the market growth. However, the market growth might be hindered by high procedural costs and stringent surrogacy laws, but, favorable reimbursement scenario is expected to reflect positively on the market growth over the forecast period.

Competitive Landscape

The Global Fertility Services Market is currently dominated by a few players who are focusing on expanding their footprint on the market via partnerships and collaborations. The global fertility services market is highly competitive Notable players in the global fertility services market include Merck KGaA (Germany), Irvine Scientific (U.S.), CARE Fertility Group Limited (U.K.), Vitrolife (U.S.), Cook Medical (U.S.), CooperSurgical Inc (U.S.), Ferring Pharmaceuticals Inc. (U.S.), and Monash IVF Group Limited.

Industry Updates

In July 2018, Gina Bartasi, former founder of Progyny, launched a new women's healthcare company that offers fertility solutions in New York and New Jersey. Named Kindbody, the company team comprises of veteran executives from the medical field.

In July 2018, Ovation Fertility announced a partnership with Midwest Fertility Specialists, the largest fertility center in Indiana. Through this partnership, both the companies will merge their laboratory and will help increase Ovation Fertility's presence in the Midwest.

Segmentation

The Global Fertility Services Market has been segmented based on underlying causes and type of treatment. By underlying causes, the market has been segmented into male fertility and female infertility. The female fertility segment is dominating the market owing to factors such as the elapsed age of motherhood, endometrial tuberculosis, prevalence of obesity, and other medical conditions among females. By type of treatment, the market has been segmented into assistive reproductive technology (ART) and infertility drugs. The ART segment has been further segmented into artificial insemination, in-vitro fertilization (IVF), frozen embryo replacement (FER), and others. ART is the leading segment owing to high success ratio of ART procedures which makes it the preferred treatment for infertility. Besides, IVF treatments have a high adoption rate since it is increasingly being covered under most reimbursement policies.

APAC: Improvement in Healthcare Infrastructure to Fuel Market Growth

The key regions in the Global Fertility Services Market include the Americas, Europe, Asia Pacific, and the Middle East & Africa. Europe is the largest market for fertility services and accounts for 34.6% share of the global market. Presence of a high number of IVF clinics & laboratories, low fertility rates and delayed marriages in the region will help Europe to achieve a growth rate of 8.50% over the forecast period. In addition, government funding and favorable reimbursement policies for fertility treatments support the growth of the market in Europe.

Geographical Overview:

The Americas are the second largest market for fertility services. The region has a robust healthcare sector and is technologically advanced which contributes to the growth of the market. Moreover, falling birth rates, the prevalence of infertility support the growth of the market. However, limited availability of donors and surrogates, stringent government regulations pertaining to fertility services such as embryo transfer and high expense of fertility services in the region are hindrances to the market growth. Asia Pacific is slated to emerge as the fastest growing market for fertility services over the forecast period.

Get Corporate Discount @ https://www.marketresearchfuture.com/check-discount/6281

The Asia Pacific market is likely to expand over the forecast period due to factors such as improving healthcare infrastructure, adoption of advanced healthcare technologies, and prevalence of infertility in the region. The cost of fertility treatments are considerably low in the region which encourages medical tourism for fertility services; however, lack of proper reimbursement policies and strict legal and ethical concerns regarding fertility treatments are impediments to the growth of the Asia Pacific market. The Middle East & Africa market is expected to witness steady growth over the forecast period. The governments in the MEA region have endeavored to educate and raise awareness among people regarding infertility complications. Moreover, available treatment options and a substantial investment in the healthcare sector acts as a tailwind for the fertility services market.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/fertility-services-market-6281

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com